Produktname:1,2-Diazenedicarboxylic acid, 1,2-bis(1,1-dimethylethyl) ester

IUPAC Name:(E)-N-{[(tert-butoxy)carbonyl]imino}(tert-butoxy)formamide

CAS:870-50-8
Molekulare Formel:C10H18N2O4
Reinheit:95%
Katalognummer:CM112364
Molekulargewicht:230.26

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM112364-100g in stock ǕȀ
CM112364-500g in stock ƞȀǯ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:870-50-8
Molekulare Formel:C10H18N2O4
Schmelzpunkt:-
SMILES-Code:O=C(/N=N/C(OC(C)(C)C)=O)OC(C)(C)C
Dichte:
Katalognummer:CM112364
Molekulargewicht:230.26
Siedepunkt:
Mdl-Nr.:MFCD00015001
Lagerung:

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

Column Infos

Carbonyl Compounds
In organic chemistry, a carbonyl group is a functional group with the formula C=O, composed of a carbon atom double-bonded to an oxygen atom, and it is divalent at the C atom. It is common to several classes of organic compounds (such as aldehydes, ketones and carboxylic acids), as part of many larger functional groups. A compound containing a carbonyl group is often referred to as a carbonyl compound.
INX-315
Incyclix Bio announces FDA clearance of investigational new drug application for INX-315 in patients with advanced or metastatic cancer. INX-315 is a novel, potent and selective inhibitor of Cyclin-dependent kinase 2 (CDK2) with compelling pre-clinical efficacy and safety data.
CDK2 is thought to play an important role in driving proliferation of certain cancers, including those harboring CCNE1 amplification and breast cancers that have acquired resistance to CDK4/6 inhibitors (CDK4/6i).

Related Products